103 related articles for article (PubMed ID: 29205734)
1. Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study.
Home P; Calvi-Gries F; Blonde L; Pilorget V; Berlingieri J; Freemantle N
Diabetes Obes Metab; 2018 Apr; 20(4):921-929. PubMed ID: 29205734
[TBL] [Abstract][Full Text] [Related]
2. Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.
Home PD; Dain MP; Freemantle N; Kawamori R; Pfohl M; Brette S; Pilorget V; Scherbaum WA; Vespasiani G; Vincent M; Balkau B
Diabetes Res Clin Pract; 2015 May; 108(2):350-9. PubMed ID: 25825361
[TBL] [Abstract][Full Text] [Related]
3. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
[TBL] [Abstract][Full Text] [Related]
4. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.
Owens DR; Bolli GB; Charbonnel B; Haak T; Landgraf W; Porcellati F; Traylor L; Kautzky-Willer A
Diabetes Obes Metab; 2017 Nov; 19(11):1546-1554. PubMed ID: 28449412
[TBL] [Abstract][Full Text] [Related]
5. Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used.
Norwood P; Chen R; Jaeckel E; Lingvay I; Jarlov H; Lehmann L; Heller S
Diabetes Obes Metab; 2017 Nov; 19(11):1562-1569. PubMed ID: 28417535
[TBL] [Abstract][Full Text] [Related]
6. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Kostev K; Dippel FW; Rathmann W
Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
[TBL] [Abstract][Full Text] [Related]
7. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
8. Predictors of HbA1c over 4 years in people with type 2 diabetes starting insulin therapies: The CREDIT study.
Balkau B; Calvi-Gries F; Freemantle N; Vincent M; Pilorget V; Home PD
Diabetes Res Clin Pract; 2015 Jun; 108(3):432-40. PubMed ID: 25818885
[TBL] [Abstract][Full Text] [Related]
9. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
Davis TME; Bruce DG; Finn J; Curtis BH; Barraclough H; Davis WA
Diabetes Obes Metab; 2019 Mar; 21(3):648-657. PubMed ID: 30370611
[TBL] [Abstract][Full Text] [Related]
10. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
UK Hypoglycaemia Study Group
Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
[TBL] [Abstract][Full Text] [Related]
11. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
[TBL] [Abstract][Full Text] [Related]
12. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Zinman B; Marso SP; Poulter NR; Emerson SS; Pieber TR; Pratley RE; Lange M; Brown-Frandsen K; Moses A; Ocampo Francisco AM; Barner Lekdorf J; Kvist K; Buse JB;
Diabetologia; 2018 Jan; 61(1):48-57. PubMed ID: 28913575
[TBL] [Abstract][Full Text] [Related]
13. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
[TBL] [Abstract][Full Text] [Related]
14. Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study.
Dunkley AJ; Fitzpatrick C; Gray LJ; Waheed G; Heller SR; Frier BM; Davies MJ; Khunti K;
Diabetes Obes Metab; 2019 Jul; 21(7):1585-1595. PubMed ID: 30843327
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitus.
Frier BM; Landgraf W; Zhang M; Bolli GB; Owens DR
Diabetes Obes Metab; 2018 Dec; 20(12):2894-2898. PubMed ID: 29943493
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs.
Signorovitch JE; Macaulay D; Diener M; Yan Y; Wu EQ; Gruenberger JB; Frier BM
Diabetes Obes Metab; 2013 Apr; 15(4):335-41. PubMed ID: 23121373
[TBL] [Abstract][Full Text] [Related]
17. Both hypo- and hyperglycaemia are associated with increased fracture risk in Japanese people with type 2 diabetes: the Fukuoka Diabetes Registry.
Komorita Y; Iwase M; Fujii H; Ohkuma T; Ide H; Yoshinari M; Oku Y; Nakamura U; Kitazono T
Diabet Med; 2020 May; 37(5):838-847. PubMed ID: 31556147
[TBL] [Abstract][Full Text] [Related]
18. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP;
Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
[TBL] [Abstract][Full Text] [Related]
19. Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.
Kristensen PL; Tarnow L; Bay C; Nørgaard K; Jensen T; Parving HH; Perrild H; Beck-Nielsen H; Christiansen JS; Thorsteinsson B; Pedersen-Bjergaard U
Diabet Med; 2017 May; 34(5):625-631. PubMed ID: 28099755
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.
Bolli GB; Riddle MC; Bergenstal RM; Wardecki M; Goyeau H; Home PD;
Diabetes Metab; 2017 Sep; 43(4):351-358. PubMed ID: 28622950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
